S-531011 as Monotherapy and in Combination With an Immune Checkpoint Inhibitor in Advanced or Metastatic Solid Tumors
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
Solid Tumors
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Angeles Clinic and Research Center, Los Angeles, California, United States
University of Florida Health, Gainesville, Florida, United States
Henry Ford Health Center, Detroit, Michigan, United States
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
MD Anderson Cancer Center, Houston, Texas, United States
National Cancer Center Hospital East, Kashiwa, Chiba, Japan
The University of Osaka Hospital, Suita, Osaka, Japan
National Cancer Center Hospital, Chuo Ku, Tokyo, Japan
Study leads
Shionogi Clinical Trials Administrator Clinical Support Help Line
Study Director
Shionogi